Highest-materiality recent filing
IQVIA Q2 revenue $4.37B up 8.7% YoY, adj EPS $3.15 up 12.1%, raises FY guidance
GAAP net income $256M, GAAP diluted EPS $1.53; adjusted EBITDA $994M (+9.2% YoY).
IQVIA Inc. prices €950M senior notes due 2033 at 4.625% for debt refinancing
Subsidiary IQVIA Inc. priced €950M aggregate principal amount of senior notes due 2033.
IQVIA board authorizes additional $2B share repurchase; total authorization reaches $3.2B
Board approved $2B increase to existing repurchase program, bringing total remaining authorization to $3.217B.
IQVIA Q1 revenue $4.15B (+8.4% YoY); adj. EPS $2.90; raises FY2026 adj. EPS guidance to $12.65-12.95
GAAP net income $274M ($1.61 EPS); Adjusted EBITDA $932M (+5.5% YoY).
IQVIA Q4 revenue up 10.3% to $4.36B; adj EPS $3.42, issues FY2026 guidance
Q4 revenue $4,364M (+10.3% YoY); GAAP EPS $2.99, adj. EPS $3.42 (+9.6% YoY).
New $2.19B Term A Dollar Loans and $2B Revolving Credit Commitments on December 9, 2025.
Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board
Appointment effective November 5, 2025.
IQVIA Q3 revenue up 5.2% to $4.1B, adj EPS $3.00; reaffirms FY guide
Revenue $4,100M (+5.2% YoY); GAAP EPS $1.93, adj EPS $3.00.
IQVIA Q2 revenue $4.017B (+5.3% YoY); adj. EPS $2.81; updates FY25 guidance to $11.75-$12.05
Revenue $4,017M (+5.3% YoY); GAAP net income $266M ($1.54 diluted EPS); adjusted diluted EPS $2.81.
IQVIA issues $2B of 6.250% senior notes due 2032 to repay revolver borrowings
IQVIA Inc., wholly owned subsidiary, issued $2B of 6.250% senior notes due June 1, 2032.
IQVIA subsidiary prices $2B senior notes at 6.250% due 2032, proceeds to repay revolver
IQVIA Inc. issues $2,000,000,000 in senior notes due 2032 bearing 6.250% annual interest.
IQVIA Q1 revenue $3,829M, adjusted EPS $2.70 (+6.3%); raises FY revenue guidance on FX
GAAP net income $249M ($1.40 EPS); adjusted EBITDA $883M (+2.4% YoY).
IQVIA refinances $1.985B term loans, cuts B-4 rate 25 bps, repays Euro loans
$1.985B new Term B-5 Dollar Loans issued to refinance Term B-4 Dollar Loans and repay Term B-2 Euro Loans.
IQVIA Q4 adj EPS $3.12 (+9.9% YoY), backlog $31.1B; reaffirms FY25 guidance
Q4 revenue $3,958M (+3.0% cc), GAAP EPS $2.42, adj EPS $3.12; FY revenue $15,405M.
IQVIA Q3 revenue $3,896M, Adj EPS $2.84 (+14.1%); FY24 guidance cut on trial delays
Q3 revenue $3,896M (+4.3% YoY); GAAP EPS $1.55; Adj EPS $2.84 (+14.1%).
IQVIA Q2 2024 revenue $3.81B (+2.3% YoY), adj EPS $2.64, updated FY guidance
Revenue $3,814M (+2.3% reported, +3.5% constant currency); GAAP net income $363M, diluted EPS $1.97.
IQVIA Q1 revenue $3,737M, adj EPS $2.54; reaffirms FY guidance with FX adjustment
GAAP EPS $1.56; adjusted EPS $2.54; adjusted EBITDA $862M (+1.3% YoY).
IQVIA reports Q4 revenue $3.87B, GAAP EPS $2.54; issues FY2024 guidance
Q4 revenue $3,868M (+3.5% YoY); GAAP net income $469M (+106.6%); adjusted EPS $2.84 (+2.2%).
IQVIA issues $1.25B 6.250% senior secured notes due 2029 and $1.5B incremental term loans
Issued $1.25B of 6.250% senior secured notes maturing February 1, 2029; interest payable semiannually.
IQVIA Q3 revenue $3.736B (+4.9%), adjusted EPS $2.49; FY23 guidance revised to $14.885-$14.92B
Revenue $3,736M (+4.9%), GAAP net income $303M (+7.1%), adjusted EBITDA $888M (+9.1%).
Revenue $3,728M, up 5.3% reported and 5.5% constant currency; R&D Solutions revenue $2,096M (+7.5%).
IQVIA subsidiary issues $1.25B in senior secured and senior notes to repay revolver
Issued $750M 5.700% senior secured notes due 2028 and $500M 6.500% senior notes due 2030.
IQVIA subsidiary prices $1.25B notes offering to refinance credit facility
IQVIA Inc. priced $750M senior secured notes due 2028 at 5.700% and $500M senior notes due 2030 at 6.500%.
IQVIA Q1 revenue $3.65B, adjusted EPS $2.45; reaffirms FY2023 guidance
Revenue $3,652M, up 2.4% reported (4.7% constant currency) vs Q1 2022.
IQVIA Q4 2022 adj EPS $2.78 (+9% YoY); FY 2023 guidance adj EPS $10.26-$10.56
Q4 revenue $3,739M (+2.8% reported, +7.0% CC); full-year revenue $14,410M (+3.9% reported).
Revenue $3,562M, +5.0% reported / +10.5% constant currency; GAAP EPS $1.49, Adj EPS $2.48 (both up ~11-14% YoY).
Revenue $3,541M (+3.0% reported, +7.1% constant currency); GAAP diluted EPS $1.34 (+48.9%); adj diluted EPS $2.44 (+14.6%).
IQVIA borrows $1.25B in incremental Term A Loans; repays $950M of revolver
Borrowed $1.25B in incremental Term A-2 Dollar Loans on June 16, 2022.
GAAP net income $325M (+53.3%), GAAP diluted EPS $1.68 (+54.1%); adjusted EBITDA $812M (+9.1%).
IQVIA stockholders approve board declassification; annual election of all directors
Proposal to declassify board approved with 158.8M for vs 0.3M against; charter and bylaws amended effective April 12, 2022.
IQVIA Q4 revenue $3.6B (+10.2%), raises FY22 profit guidance; backlog record $24.8B
Q4 GAAP diluted EPS $1.63 (+167% YoY); Adjusted diluted EPS $2.55 (+20.9%); Revenue $3,636M (+10.2% reported).
IQVIA Q3 revenue $3,391M (+21.7% YoY), raises full-year 2021 guidance
Q3 GAAP diluted EPS $1.34 (up 157.7% YoY); adjusted diluted EPS $2.17 (up 33.1% YoY).
IQVIA refinances $2.7B credit facilities, extends maturity to 2026, reduces interest rates
New Term A Dollar Loans of $1,451M and Term A Euro Loans of €317M refinanced; maturity extended from 2023 to 2026.
IQVIA Q2 revenue $3,438M (+36.4% YoY); raises full-year guidance
GAAP diluted EPS $0.90 vs. $(0.12) YoY; adjusted diluted EPS $2.13, up 80.5%.
On May 6, 2024, IQVIA Holdings Inc. (the “Company”) announced that Kevin C. Knightly, President, Corporate Strategy and Enterprise Networks, will transition from his current role effective May 15, 2024, and will become a senior advisor to the Chief Executive Officer (the “CEO”).
On September 24, 2023, Costa Panagos informed the Company of his intention to leave the Company.
On September 25, 2023, IQVIA Holdings Inc. (the “Company”) announced the appointment of Richard Staub III to serve as President of its Research & Development Solutions (“R&DS”) business unit, effective September 25, 2023.
IQVIA Holdings Inc. (the “Company”) announced today the resignation of Ronald A. Rittenmeyer, a member of the board of directors (the “Board”) and chairman of the Leadership Development and Compensation Committee (“LDCC”) of the Company, due to personal health reasons effective as of October 2, 2022.
IQVIA Holdings Inc. (the “Company”) announced today the appointment of Keriann Cherofsky as Senior Vice President, Corporate Controller and principal accounting officer of the Company, effective August 1, 2022.
On July 25, 2022, Emmanuel Korakis, Senior Vice President, Corporate Controller and Treasurer, informed the Company of his intention to leave the Company to become Chief Financial Officer of Presidio, Inc. Mr. Korakis’ last day will be July 31, 2022.
On March 14, 2022, IQVIA Holdings Inc. (the “Company”) announced the appointment of Costa Panagos as President of its Research & Development Solutions (“R&DS”) business unit, effective April 1, 2022.
Richard Staub III, President, R&DS, will retire from his current role effective April 1, 2022
The Board of Directors (the “Board”) of IQVIA Holdings Inc. (the “Company”) appointed Leslie Wims Morris and Sheila A. Stamps to the Board on January 24, 2022 and January 26, 2022, respectively.
The Board of Directors (the “Board”) of IQVIA Holdings Inc. (the “Company”) appointed Leslie Wims Morris and Sheila A. Stamps to the Board on January 24, 2022 and January 26, 2022, respectively.
Max materiality 0.85 · Median 0.65 · Most common event earnings